As co-founder and CEO of Mammoth Biosciences, Dr. Trevor Martin is spearheading the development of the next generation of CRISPR therapies to potentially permanently cure genetic diseases by reading and writing the code of life. Trevor earned his BA from Princeton University and his Ph.D. in Biology from Stanford. His scientific work has been featured in outlets including FiveThirtyEight and The Atlantic. He is the featured healthcare honoree on the Forbes 30 Under 30 list, is on Fortune’s 40 Under 40 list, and is an EY Entrepreneur of the Year 2021.